| 1 |
Ung M, Rouquette I, Filleron T, et al. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung[J]. Clin Lung Cancer, 2016, 17(5): 391-397.
|
| 2 |
Kim TS, Han J, Lee KS, et al. CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients[J]. AJR Am J Roentgenol, 2005, 185(1): 120-125.
|
| 3 |
Kim TH, Kim SJ, Ryu YH, et al. Pleomorphic carcinoma of lung: comparison of CT features and pathologic findings[J]. Radiology, 2004, 232(2): 554-559.
|
| 4 |
Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors[J]. Semin Roentgenol, 2005, 40(2): 90-97.
|
| 5 |
Pelosi G, Melotti F, Cavazza A, et al. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples[J]. Anticancer Res, 2012, 32(4): 1463-1473.
|
| 6 |
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260.
|
| 7 |
李园园，张丽丽，蒋娟，等. 38例肺肉瘤样癌临床特点及预后的回溯性分析[J]. 中国肺癌杂志，2015, 18: 6.
|
| 8 |
徐晓莉，宋伟，隋昕，等. 原发性肺肉瘤样癌的CT表现与病理特点[J]. 中国医学科学院学报，2016, 38: 6.
|
| 9 |
Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic，sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases[J]. Am J Surg Pathol, 2003, 27(3): 311-324.
|
| 10 |
Fishback NF, Travis WD, Moran CA, et al. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases[J]. Cancer, 1994, 73(12): 2936-2945.
|
| 11 |
Blum RH, Carter SK. Adriamycin. A new anticancer drug with significant clinical activity[J]. Ann Intern Med, 1974, 80(2): 249-259.
|
| 12 |
Pelosi G, Fraggetta F, Nappi O, et al. Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases[J]. Am J Surg Pathol, 2003, 27(9): 1203-1215.
|
| 13 |
Humphrey PA, Scroggs MW, Roggli VL, et al. Pulmonary carcinomas with a sarcomatoid element: an immunocytochemical and ultrastructural analysis[J]. Hum Pathol, 1988, 19(2): 155-165.
|
| 14 |
涂茜，黄信华，贾铭，等. 肺巨细胞癌一例[J]. 放射学实践，2007, 22: 321.
|
| 15 |
戚跃勇，王文献，张哉根. 2例肺梭形细胞癌的影像诊断[J]. 第三军医大学学报，1999, 21(2): 102.
|
| 16 |
张秀兰，刘惠萍，赵东，等. 右肺巨细胞癌伴全身广泛转移1例[J]. 心血管病杂志，2001, 21: 100.
|
| 17 |
Alasio TM, Sun W, Yang GC. Giant cell carcinoma of the lung impact of diagnosis and review of cytological features[J]. Diagn Cytopathol, 2007, 35(9): 555-559.
|
| 18 |
Addis BJ, Dewar A, Thurlow NP. Giant cell carcinoma of the lung-immunohistochemical and ultrastructural evidence of dedifferentiation[J]. J Pathol, 1988, 155(3): 231-240.
|
| 19 |
Attanoos RL, Papagiannis A, Suttinont P, et al. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype？[J]. Histopathology, 1998, 32(3): 225-231.
|
| 20 |
Kim KI, Flint JD, Muller NL. Pulmonary carcinosarcoma: radiologic and pathologic findings in three patients[J]. AJR Am J Roentgenol, 1997, 169(3): 691-694.
|
| 21 |
杨新国，田昭俭，吴起嵩. 原发性肺肉瘤样癌的病理亚型及其CT表现[J]. 实用放射学杂志，2013, 29(9): 1429-1433.
|
| 22 |
Ishida T, Tateishi M, Kaneko S, et al. Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies[J]. J Thorac Cardiovasc Surg, 1990, 100(6): 844-852.
|
| 23 |
Koss MN, Hochholzer L, Frommelt RA. Carcinosarcomas of the lung：a clinicopathologic study of 66 patients[J]. Am J Surg Pathol, 1999, 23(12): 1514-1526.
|
| 24 |
Wick MR, Ritter JH, Humphrey PA. Sarcomatoid carcinomas of the lung: a clinicopathologic review[J]. Am J Clin Pathol, 1997, 108(1): 40-53.
|
| 25 |
Koss MN, Hochholzer L, O′Leary T. Pulmonary blastomas[J]. Cancer, 1991, 67(9): 2368-2381.
|
| 26 |
Inoue H, Kasai K, Shinada J, et al. Pulmonary blastoma. Comparison between its epithelial components and fetal bronchial epithelium[J]. Acta Pathol Jpn, 1992, 42(12): 884-892.
|
| 27 |
Garcia-Escudero A, Gonzalez-Campora R, Villar-Rodriguez JL, et al. Thyroid transcription factor-1 expression in pulmonary blastoma[J]. Histopathology, 2004, 44(5): 507-508.
|
| 28 |
Pacinda SJ, Ledet SC, Gondo MM, et al. p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas[J]. Hum Pathol, 1996, 27(6): 542-546.
|
| 29 |
Terra SB, Jang JS, Bi L, et al. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases[J]. Mod Pathol, 2016, 29(8): 824-831.
|
| 30 |
Pelosi G, Gasparini P, Conte D, et al. Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid carcinoma, a deadly subtype of lung cancer[J]. J Thorac Oncol, 2016, 11(5): 718-728.
|
| 31 |
Lee S, Kim Y, Sun JM, et al. Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy[J]. J Cancer Res Clin Oncol, 2011, 137(8): 1203-1211.
|
| 32 |
Chang YL, Wu CT, Shih JY, et al. EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy[J]. Ann Surg Oncol, 2011, 18(10): 2952-2960.
|
| 33 |
Przygodzki RM, Koss MN, O'Leary TJ. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12[J]. Mol Diagn, 2001, 6(2): 109-115.
|
| 34 |
Vieira T, Antoine M, Ruppert AM, et al. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung[J]. Lung Cancer, 2014, 85(2): 276-281.
|
| 35 |
Iizuka M, Shiraishi M, Yoshida MC, et al. Joining of the c-myc gene and a line 1 family member on chromosome 8 in a human primary giant cell carcinoma of the lung[J]. Cancer Res, 1990, 50(11): 3345-3350.
|
| 36 |
Holst VA, Finkelstein S, Colby TV, et al. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis[J]. Am J Surg Pathol, 1997, 21(7): 801-811.
|
| 37 |
Toyokawa G, Takenoyama M, Taguchi K, et al. The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene[J]. Lung Cancer, 2013, 81(3): 491-494.
|
| 38 |
Sekine S, Shibata T, Matsuno Y, et al. Beta-catenin mutations in pulmonary blastomas: association with morule formation[J]. J Pathol, 2003, 200(2): 214-221.
|
| 39 |
Macher-Goeppinger S, Penzel R, Roth W, et al. Expression and mutation analysis of EGFR, c-KIT, and beta-catenin in pulmonary blastoma[J]. J Clin Pathol, 2011, 64(4): 349-353.
|
| 40 |
Pardo J, Aisa G, de Alava E, et al. Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas[J]. Diagn Mol Pathol, 2008, 17(3): 151-158.
|